A clear map of where you are and where you are going is certainly a critical step to leading your team into a successful Digital Transformation. I spoke about this during my talk at the 2019 Digital Pharma East conference in the video below.
THE MOLE PERSPECTIVE
I recently spoke on digital transformation in pharma at the Digital Health Coalition (DHC) Summit hosted by AstraZeneca. Here is a link to the featured content of the Summit: DHC October 2019
Virtually everyone that spoke to me after my talk pressed me to provide more details surrounding the MOLE concept that I presented and asked for more information on the 2020 workshop. I’m proud to announce the workshop is complete, I’ve setup some events and I’ve summarized some key elements of the MOLE workshop for you in this series of 2 blogs. Enjoy…and please reach out with any questions or comments below.
The pharmaceutical industry’s implementation of digital marketing and use of a true multiple channel strategy has been under pressure for the past 10 years as virtually every other industry and sector has surpassed them in both customer-centricity and progress in digital marketing. Many pharma companies both big and small have been testing the integration of a customer engagement digital commercial model during this time. Some may ask, Neil, “What exactly is digital transformation?” Brian Solis, a digital analyst and best-selling author, has done significant amount of work in the digital space defines digital transformation as follows:
“Greatness is not a function of circumstance. Greatness, it turns out, is largely a matter of conscious choice, and discipline.” ― James C. Collins, Good to Great: Why Some Companies Make the Leap… and Others Don’t
Good to Great was published back in 2001; however, I believe the quote above still serves as an overall guide for marketing organizations’ need to create innovation in